Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 385 clinical trials
Stepped Care for Youth at Risk of Psychosis

The study will recruit 60 young people who meet established criteria for being at clinical high risk for psychosis. They will be offered a range of psychological interventions starting with the

  • 12 views
  • 08 Jun, 2022
  • 1 location
TMCU for Young Adults With First Episode Psychosis

We propose to pilot test an adapted version of the Teen Marijuana Check Up (TMCU) for persistent cannabis users with first episode psychosis (FEP) in Coordinated Specialty Care (CSC). The

  • 0 views
  • 04 Oct, 2022
  • 1 location
Improving Family Engagement in Coordinated Specialty Care for First Episode Psychosis

episode psychosis. First, 5 family member participants will be recruited into a three-month trial of FAMES and implementation toolkit. The investigators will then conduct a 16-month non-randomized

  • 0 views
  • 04 Oct, 2022
  • 1 location
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

This is an open-label, sequential cohorts, flexible dose study to evaluate the tolerability, safety and pharmacokinetics of iloperidone in elderly patients with Parkinson's disease psychosis

  • 0 views
  • 16 Jun, 2022
  • 1 location
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST) (InVEST)

The purpose of this study is to test the efficacy of InVEST (Individualized Vocational and Educational Support and Training) for CHR-P (clinical high risk for psychosis) to address specific role

  • 0 views
  • 28 Jun, 2022
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

augmented with Cannabidiol Oral Solution (CBD) or with a matching CBD placebo for 8 weeks. The study will examine CBD as an augmentation strategy in early psychosis. It is hypothesized that CBD will improve

  • 0 views
  • 22 Jun, 2021
  • 2 locations
Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity

-LCP) on the physical and psychosocial health outcomes of patients with early psychosis over a 12-week follow-up.

  • 21 views
  • 07 Oct, 2022
  • 1 location
Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia (OXYGEN)

Recent studies indicated positive effects of mindfulness-based interventions (MBI) for schizophrenia (SCZ), but also on oxytocin (OXT) levels in healthy persons. It was also shown that response to MBI could be shaped by genetic factors. However, the interplay between mindfulness and empathy and genetic factors with the oxytocinergic system has …

  • 0 views
  • 04 Oct, 2022
  • 1 location
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

disorder may be effective at reducing psychosis or altering the course of the disease, there are currently no biomarkers capable of identifying subjects in early stages of SZ who are likely to respond to

Accepts healthy volunteers
  • 7 views
  • 04 Oct, 2022
  • 1 location
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease Dementia (ADEPT-1)

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease dementia. The

  • 0 views
  • 27 Oct, 2022
  • 1 location